Table 1.
Baseline characteristics of study patients with and without depression and anxiety disorder diagnosis.
Variable | Patients without depression (N = 26,341)a | Patients with depression (N = 1970)a | P-valueb | Patients without anxiety disorder (N = 27,942)a | Patients with anxiety disorder (N = 369)a | P-valueb |
---|---|---|---|---|---|---|
Female | 47.5 | 62.6 | <0.001 | 48.4 | 61.2 | <0.001 |
Age (Mean, SD) | 66 (21) | 63 (22) | <0.001 | 65 (21) | 59 (19) | <0.001 |
Cancer | 5.5 | 4.0 | 0.004 | 5.4 | 7.0 | 0.15 |
Diabetes mellitus | 22.7 | 20.0 | 0.005 | 22.6 | 19.0 | 0.10 |
Lipid metabolism disorder | 15.1 | 17.8 | 0.001 | 15.3 | 13.0 | 0.22 |
Obesity | 5.2 | 6.3 | 0.036 | 5.3 | 9.2 | <0.001 |
Heart failure | 14.3 | 15.3 | 0.22 | 14.4 | 11.1 | 0.07 |
Ischemic heart disease, | 13.9 | 12.7 | 0.14 | 13.8 | 12.5 | 0.46 |
Cerebrovascular disease | 7.4 | 10.4 | <0.001 | 7.6 | 6.2 | 0.32 |
Cirrhosis of the liver | 0.9 | 0.9 | 0.85 | 0.9 | 0.3 | 0.27 |
Omicron variant | 41.0 | 44.1 | 0.006 | 41.2 | 40.4 | 0.75 |
No omicron variant | 59.0 | 55.9 | 58.8 | 59.6 |
Data are presented as percentages unless otherwise specified.
Welch Two Sample t-test; two-sample test for equality of proportions.